ESC Premium Access

Apixaban vs conventional therapy in anticoagulation-naive patients with atrial fibrillation undergoing cardioversion: The EMANATE Trial

Congress Session

About the speaker

Professor Michael D Ezekowitz

Thomas Jefferson University Hospital, Philadelphia (United States of America)
3 presentations
0 follower

17 more presentations in this session

SPYRAL HTN OFF-MED Study

Speaker: Professor M. Boehm (Homburg, DE)

Thumbnail

Discussant review: SPYRAL HTN OFF-MED Study

Speaker: Professor B. Williams (London, GB)

Thumbnail

Panel discussion.

Thumbnail

Discussant review:Apixaban vs conventional therapy in anticoagulation-naive patients with atrial fibrillation undergoing cardioversion: The EMANATE Trial

Speaker: Professor J. Nielsen (Aarhus, DK)

Thumbnail

Panel discussion.

Thumbnail

Access the full session

Hot Line: Late-Breaking Clinical Trials 2

Speakers: Professor M. Ezekowitz, Professor M. Boehm, Professor B. Williams, Professor J. Nielsen
Thumbnail

About the event

Image

ESC CONGRESS 2017

26 August - 30 August 2017

Sessions Presentations

This platform is supported by

logo Novo Nordisk